Alternative Angiotensin II Formation in Rat Arteries Occurs Only at Very High Concentrations of Angiotensin I
- 1 September 1999
- journal article
- other
- Published by Wolters Kluwer Health in Hypertension
- Vol. 34 (3), 525-530
- https://doi.org/10.1161/01.hyp.34.3.525
Abstract
Abstract —Contrary to previous reports, recent enzymatic assays showed the predominance of chymase-like activity in rat arteries. We determined the existence and significance of such alternative pathways in rat carotid arteries by measuring contraction of arterial rings in organ baths and blood pressure in conscious rats. Hamster aorta served as a positive control for chymase. Temocapril (30 μmol/L) inhibited the contractions to angiotensin (Ang) I (10 −9 to 10 −5 mol/L) except at high concentrations of Ang I (>10 −7 mol/L). Addition of chymostatin (100 μmol/L) to temocapril exerted a synergistic inhibitory effect. Hamster aorta gave similar results, except that temocapril was 30-fold less effective than in rat arteries. [Pro 11 , d -Ala 12 ]Ang I (10 −8 to 10 −5 mol/L), a chymase-specific substrate, provoked similar responses in rat and hamster arteries; chymostatin, but not temocapril, attenuated the responses. CV 11974 (30 μmol/L), an Ang II type 1 receptor antagonist, abolished the responses to both peptides. In conscious rats, Ang I (0.03 to 30 μg/kg) and [Pro 11 , d -Ala 12 ]Ang I (7 to 700 μg/kg) produced similar pressor responses. Not only CV 11974 (1 mg/kg) but also temocapril (2 mg/kg) abolished Ang I–induced responses in vivo. CV 11974, but not temocapril, inhibited responses to [Pro 11 , d -Ala 12 ]Ang I. Our results showed the presence of the alternative pathway in rat arteries, but it did not play a major role. Arteries with the opposing characteristics of chymase responded equally to [Pro 11 , d -Ala 12 ]Ang I. These findings suggest that biochemical and [Pro 11 , d -Ala 12 ]Ang I–derived results may not reflect the functional significance of chymase.Keywords
This publication has 17 references indexed in Scilit:
- Dual pathway for angiotensin II formation in human internal mammary arteriesBritish Journal of Pharmacology, 1998
- Compartmentalization of angiotensin II generation in the dog heart. Evidence for independent mechanisms in intravascular and interstitial spaces.Journal of Clinical Investigation, 1997
- Purification and characterization of angiotensin II-generating chymase from hamster cheek pouchLife Sciences, 1996
- A comparison of the effect of angiotensin converting enzyme inhibition and angiotensin II receptor antagonism on the structural changes associated with hypertension in rat small arteriesJournal Of Hypertension, 1995
- Effects of angiotensin II generated by an angiotensin converting enzyme-independent pathway on left ventricular performance in the conscious baboon.Journal of Clinical Investigation, 1995
- Vasoconstrictor action of angiotensin I-convertase and the synthetic substrate (Pro11,D-Ala12)-angiotensin I.Hypertension, 1994
- Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart.Journal of Clinical Investigation, 1993
- Microinjection of α-Calcitonin Gene-Related Peptide into the Hypothalamus Activates Sympathetic Outflow in RatsThe Japanese Journal of Pharmacology, 1993
- Substrate-dependent angiotensin II formation in the peripheral circulationLife Sciences, 1990
- Different distribution of two types of angiotensin II-generating enzymes in the aortic wallBiochemical and Biophysical Research Communications, 1987